Are child-, adolescent-, and adult-onset depression one and the same disorder?

Biological Psychiatry

Volumn 49, Issue 12, 2001, Pages 980-1001

  Kaufman, Joan ^a   Martin, Andrés ^a   King, Robert A ^a   Charney, Dennis ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Adolescents; Children; Depression; Neurobiology

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; FLUOXETINE; GROWTH HORMONE; HYDROCORTISONE; IMIPRAMINE; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; THYROID HORMONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENCE; ADULT; BRAIN DEVELOPMENT; CELLULAR IMMUNITY; CHILD; COMPARATIVE STUDY; CORTICOTROPIN TEST; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; HUMAN; HYDROCORTISONE RELEASE; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL RESEARCH; NEUROBIOLOGY; ONSET AGE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN; CHILD; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; DIAGNOSIS, DIFFERENTIAL; GROWTH HORMONE-RELEASING HORMONE; HUMANS; HYDROCORTISONE; IMMUNITY, CELLULAR; MAGNETIC RESONANCE IMAGING; SEROTONIN; THYROID HORMONES;

EID: 0035875143     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01127-1     Document Type: Review

References (187)

1. Parallel organization of functionally segregated circuits linking basal ganglia and cortex
2. Functional development of the dorsolateral prefrontal cortex: An analysis utlizing reversible cryogenic depression
3. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects
4. The dexamethasone suppression test: An overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry
5. Depression in adolescents and young adults-polysomnographic and neuroendocrine aspects
6. The role of corticotropin-releasing factor in depression and anxiety disorders
7. Cortisol secretion in relation to age in major depression
8. Hypercortisolemia and hippocampal changes in depression
9. Immune differences in children with and without depression
10. Reduction of prefrontal cortex glucose metabolism common to three types of depression
11. The anatomy of meloncholia- focal abnormalities of cerebral blood flow in major depression
12. Indole-pyruvic acid, a tryptophan ketoanalogue, antagonizes the endocrine but not the behavioral effects of repeated stress in a model of depression
13. Corticotropin-releasing hormone challenge in prepubertal major depression
14. The dexamethasone suppression test in adolescent outpatients with major depressive disorder
15. Growth hormone secretion in children and adolescents at high risk for major depressive disorder
16. Neuroendocrine response to 5-hydroxy-L-tryptophan in prepubertal children at high risk of major depressive disorder
17. Cellular immunity in depressed, conduct disorder, and normal adolescents: Role of adverse life events
18. Dexamethasone suppression test in children with major depressive disorder
19. Childhood and adolescent depression: A review of the past 10 years. Part I
20. Serotonin 5-HT2 receptor imaging in major depression: Focal changes in orbito-insular cortex
21. An epidemiological twin study of prefrontal neuromorphometry in early onset depression
22. Twin study of brain morphometry in adolescent- or earlier-onset depression
23. Neuroendocrine investigation in children and adolescents with dysthymic disorders: The DST, TRH and clonidine tests
24. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse
25. Hippocampal volume reduction in major depression
26. The dexamethasone suppression test for melancholia
27. Structural and functional brain development and its relation to cognitive development
28. Age at onset and causes of disease
29. Cortisol secretion in adolescents with major depressive disorder
30. Low growth hormone response to growth hormone-releasing hormone in child depression
31. The dexamethasone suppression test in children and adolescents: A review and a controlled study
32. EEG sleep in adolescents with major depression: The role of suicidality and inpatient status
33. Electroencephalographic sleep measures in prepubertal depression
34. Sleep onset abnormalities in depressed adolescents
35. 24-Hour cortisol measures in adolescents with major depression: A controlled study
36. Developmental traumatology. Part II: Brain development
37. Cortisol dynamics and test performance of the dexamethasone suppression test in 97 psychiatrically hospitalized children aged 3-16 years
38. Thyroid hormone concentrations in depressed and nondepressed adolescents: Group differences and behavioral relations
39. Response to oCRH in depressed and nondepressed adolescents: Does gender make a difference?
40. Baseline thyroid hormones in depressed and non-depressed pre- and early-pubertal boys and girls
41. Neuroimaging studies of mood
42. Functional neuroimaging studies of depression: The anatomy of melancholia
43. Subgenual prefrontal cortex abnormalities in mood disorders
44. Cell atrophy and loss in major depression
45. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression
46. Children with major depression show reduced rapid eye movement latencies
47. Sleep EEG features of adolescents with major depression
48. Depression and dexamethasone suppression testing in children and adolescents
49. Use of the dexamethasone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents
50. The dexamethasone suppression test in depressed adolescents
51. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia?
52. Psychotic and depressed children: A new entity
53. Self-report vs. biological markers in assessment of childhood depression
54. Neuropsychological correlates of psychopathology in an unselected cohort of young adolescents
55. Desensitization of the D1 dopamine receptors in rats reproduces a model of escape deficit reverted by imipramine, fluoxetine and clomipramine
56. Thyroid stimulating hormone response to thyrotropin in prepubertal depression
57. Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder
58. Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design
59. Child and adolescent bipolar disorder: A review of the past 10 years
60. Preliminary data on the dexamethasone suppression test in children with major depressive disorder
61. Brain activity during transient sadness and happiness in healthy women
62. Responses to serotonergic prob (mCPP) in depressed and control adolescents
63. Polysomnographic parameters in first-degree relatives of unipolar probands
64. EEG sleep of young adults with major depression: A controlled study
65. Electroencephalographic sleep of adolescents with major depression and normal controls
66. Abnormal ACTH and cortisol responses to ovine corticotropin releasing factor in patients with primary affective disorder
67. Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys
68. Adrenal secretion during major depression in 8- to 16-year-olds, I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation
69. Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability?
70. The dexamethasone suppression test in adolescent psychiatric patients
71. Effect of age and sex on cortisol secretion in depressives and normals
72. Neuroendocrine and immune system pathology in psychiatric disease
73. Psychiatric disorders in the relatives of depressed probands. I. Comparison of prepubertal, adolescent and early adult onset cases
74. Altered neuroendocrine activity in maltreated children related to symptoms of depression
75. Temporal lobe measurement in primary affective disorder by magnetic resonance imaging
76. Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis
77. Depression and immunity: A meta-analytic review
78. The effect of concomitant disorders in childhood depression on predicting treatment response
79. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain
80. Growth hormone dysregulation in children with major depressive disorder
81. Depression in a sample of 9-year-old children, Prevalence and associated characteristics
82. Amitriptyline in children with major depressive disorder: A double-blind crossover pilot study
83. Depressive disorders in maltreated children
84. Psychopathology in the relatives of depressed-abused children
85. The corticotropin-releasing hormone challenge in depressed abused, depressed nonabused, and normal control children
86. Serotonergic functioning in depressed abused children: Clinical and familial correlates
87. Neurobiological correlates of child abuse
88. The neurobiology of child and adolescent depression
89. Multi-center trial of paroxetine and imipramine in the treatment of adolescent depression
90. Biochemical profile of depressed adolescents
91. Recent pharmacologic advances in antidepressant therapy
92. Identification of depression in children and adolescents: The role of the dexamethasone suppression test
93. Desipramine treatment in adolescent depression
94. Presentation and course of major depressive disorder during childhood and later years of the life span
95. A controlled family history study of childhood-onset depressive disorder
96. Depressive disorders in childhood. II. A longitudinal study of the risk for a subsequent major depression
97. A psychobiological theory of attachment
98. Clinical effects of amitriptyline in adolescent depression. A pilot study
99. Distinct mechanism for antidepressant activity by blockade of central substance P receptors
100. Long-term treatment of depression
101. Response to desipramine treatment in adolescent depression: A fixed-dose, placebo-controlled trial
102. Nocturnal cortisol, thyroid stimulating hormone, and growth hormone secretory profiles in depressed adolescents
103. REM latency in endogenously depressed adolescents
104. A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression
105. Postnatal development of monoamine contect and synthesis in the cerebral cortex of rhesus monkeys
106. EEG sleep in depressed adolescents
107. Neuroanatomical correlates of happiness, sadness, and disgust
108. Major depression in community adolescents: Age at onset, episode duration, and time to recurrence
109. Scheduling of monoaminergic neurotransmitter receptor expression in the primate neocortex during postnatal development
110. Depression, anxiety and the dexamethasone suppression test in hospitalized prepubertal children
111. The serotonin hypothesis of major depression
112. Pharmacotherapy of early-onset depression. Update and new directions
113. Cingulate function in depression: A potential predictor of treatment response
114. Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness
115. Characteristics of adolescent girls with depressive symptoms in a so-called "normal" sample
116. Reduced effect of antidepressant treatment on prolactin response to a serotonin agonist in prepubertal rats
117. Cognitive correlates of depressive symptoms in 11-year-old children
118. Quantitative MRI of the hippocampus and amygdala in severe depression
119. Depression and growth hormone
120. Plasma dexamethasone levels in children given the dexamethasone suppression test
121. Imipramine treatment of depressed children: A double-blind pilot study
122. GABA and mood disorders: A brief review and hypothesis
123. Intracortical glutamate injection produces helpless-like behavior in the rat
124. The dexamethasone suppression test in depressed, dysthymic, and nondepressed children
125. Psychopathology and plasma cortisol responses to dexamethasone in prepubertal psychiatric inpatients
126. Diffusion tensor MR imaging of the human brain
127. Neuroendocrine response to fenfluramine challenge in boys. Associations with aggressive behavior and adverse rearing
128. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis
129. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
130. Depression in prepubertal children: Dexamethasone nonsuppression predicts differential response to imipramine vs. placebo
131. Recent clinical development with reversible and selective amine oxidase inhibitors: A valuable addition to the armamentarium. Chairman's introduction
132. Plasma GABA in children and adolescents with mood, behavior, and comorbid mood and behavior disorders: A preliminary study
133. Cortisol secretion in prepubertal children with major depressive disorder. Episode and recovery
134. Depression in childhood and adolescence
135. A controlled family history study of prepubertal major depressive disorder
136. Sleep architecture and REM sleep measures in prepubertal children with major depression: A controlled study
137. The psychosocial functioning and family environment of depressed adolescents
138. Growth hormone secretion in prepubertal children with major depression. I. Final report on response to insulin-induced hypoglycemia during a depressive episode
139. Imipramine in prepubertal major depressive disorders
140. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression
141. The relationship between longitudinal clinical course and sleep and cortisol changes in adolescent depression
142. Contribution of development to buspirone effects on REM sleep: A preliminary report
143. Unipolar depression in adolescents: Clinical outcome in adulthood
144. Childhood depression and risk of suicide: A preliminary report of a longitudinal study
145. Psychiatric disorders in the relatives of depressed probands. II. Familial loading for comorbid non-depressive disorders based upon proband age of onset
146. Sleep and affective disorders
147. Preliminary report on the dexamethasone suppression test in adolescents
148. The dexamethasone suppression test in psychiatrically hospitalized adolescents
149. Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: A tyrosine hydroxylase immunohistochemical analysis
150. Magnetic resonance imaging of children without sedation: Preparation with simulation
151. The biology of depression in children and adolescents
152. Neuroendocrine response to L-5-hydroxytryptophan challenge in prepubertal major depression. Depressed vs normal children
153. Stimulatory tests of growth hormone secretion in prepubertal major depression: Depressed versus normal children
154. The clinical picture of major depression in children and adolescents
155. Growth hormone response to desmethylimipramine in depressed and suicidal adolescents
156. Parenteral clomipramine challenge in depressed adolescents: Mood and neuroendocrine response
157. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy
158. Differential rearing affects corpus callosum size and cognitive function of rhesus monkeys
159. Mood disorders: Biochemical aspects
160. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study
161. Natural killer cell activity in adolescents with major depression
162. Amygdala core nuclei volumes are decreased in recurrent major depression
163. Hippocampal atrophy in recurrent major depression
164. Basal thyroid indices in adolescent depression and bipolar disorder
165. The adolescent brain and age-related behavioral manifestations
166. Comorbidity in the interpretation of dexamethasone suppression test results in children: A review and report
167. MRS in depressed adolescents
168. Structural abnormalities in brain magnetic resonance images of depressed children
169. Mirtazapine: An antidepressant with noradrenergic and specific serotonergic effects
170. The course of major depressive disorder in adolescents: I. Recovery and risk of manic switching in a follow-up of psychotic and nonpsychotic subtypes
171. Prefrontal and cerebellar abnormalities in major depression: Evidence from oculomotor studies
172. Measurement of cortisol and lymphocyte subpopulations in depressed and conduct disordered adolescents
173. The dexamethasone suppression test in adolescent psychiatric inpatients
174. Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: I. Comparison during acute depressive states
175. Abnormal amygdala response to fearful faces in anxious and depressed children
176. Hippocampal volume in primary unipolar major depression: A magnetic resonance imaging study
177. Hormonal responses to dextroamphetamine in depressed and normal adolescents
178. Depression and anxiety disorders in parents and children. Results from the Yale family study
179. Depressed adolescents grown up
180. The dexamethasone suppression test in hospitalized prepubertal depressed children
181. The dexamethasone suppression test in prepubertal depressed children
182. A case-control family history study of depression in adolescents
183. The development and validity of familial subtypes in primary unipolar depression
184. The dexamethasone suppression test and the Children's Depression Inventory in psychiatric disorders in children
185. The sleep of childhood depressives: Comparison with age-matched controls